TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value ($000): $187,513 (89.7% shares, 10.3% debt)

Holdings (7)

HRTX HERON THERAPEUTICS INC 43.3%

Value ($000) $81,183 Shares 6,197,198 Est. Cost $13.95 Unrealized +12.5%

— LA JOLLA PHARMACEUTICAL CO 29.8%

Value ($000) $55,941 Shares 3,191,165 Est. Cost $15.19 Unrealized —

— IGNYTA INC 11.2%

Value ($000) $21,056 Shares 3,972,800 Est. Cost $5.43 Unrealized —

— OPKO HEALTH INC 10.3%

Value ($000) $19,355 Shares 14,000,000 Est. Cost $1.47 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 4.0%

Value ($000) $7,473 Shares 90,215 Est. Cost $62.32 Unrealized +38.0%

— CYCLACEL PHARMACEUTICALS INC 1.0%

Value ($000) $1,904 Shares 359,900 Est. Cost $6.00 Unrealized —

— ATYR PHARMA INC 0.3%

Value ($000) $601 Shares 279,425 Est. Cost $3.57 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HRTX	HERON THERAPEUTICS INC	6,197,198	$81,183	43.3%	$13.95	+12.5%	COM	427746102
—	LA JOLLA PHARMACEUTICAL CO	3,191,165	$55,941	29.8%	$15.19	—	COM	503459604
—	IGNYTA INC	3,972,800	$21,056	11.2%	$5.43	—	COM	451731103
—	OPKO HEALTH INC	14,000,000	$19,355	10.3%	$1.47	—	DEBT 3.0% 2/1/33	68375NAB9
BMRN	BIOMARIN PHARMACEUTICAL INC	90,215	$7,473	4.0%	$62.32	+38.0%	COM	09061G101
—	CYCLACEL PHARMACEUTICALS INC	359,900	$1,904	1.0%	$6.00	—	COM	23254L405
—	ATYR PHARMA INC	279,425	$601	0.3%	$3.57	—	COM	002120103